Kyto Technology & Life Science, Inc. - FORM 10-Q - EX-32.1 - CERTIFICATE PURSUANT TO SECTION 18 U.S.C. PURSUANT TO SECTION 906 OF THE SARBANE - August 14, 2017

Attached files

file filename
EX-31.2 - CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF - Kyto Technology & Life Science, Inc.kbph_ex312.htm
EX-31.1 - CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF - Kyto Technology & Life Science, Inc.kbph_ex311.htm
10-Q - QUARTERLY REPORT - Kyto Technology & Life Science, Inc.kbph_10q.htm
 
 
 
EXHIBIT 32.1
 
 
 
 
 
Section 1350 Certification
 
In connection with the Quarterly Report of Kyto Biopharma Inc. (the “Company”) on Form 10-Q for the period ended June 30, 2017 as filed with the Securities and Exchange Commission (the “Report”), I, Georges Benarroch, Chief Executive Officer and principal financial and accounting officer, of the Company, certify, pursuant to 18 U.S.C. SS. 1350, as adopted pursuant to SS. 906 of the Sarbanes-Oxley Act of 2002, that:
 
1.
The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, and
 
2.
The information contained in the Report fairly presents, in all material respects, the financial conditions and results of operations of the Company.
 
 
 
 
 
 
 
 
 
 
Date: August 14, 2017
 
/s/ Georges Benarroch
 
 
 
Georges Benarroch
Chief Executive Officer, principal executive officer,
principal financial and accounting officer
 
 
 
 
 
 

Kyto Technology & Life Science, Inc. Reports